JANX

JANX

USD

Janux Therapeutics Inc. Common Stock

$27.010+0.240 (0.897%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$26.770

High

$27.660

Low

$26.330

Volume

1.16M

Company Fundamentals

Market Cap

1.6B

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

0.91M

Exchange

NGM

Currency

USD

52-Week Range

Low $21.73Current $27.010High $71.71

Related News

Analyst Upgrades

Barclays Initiates Coverage On Janux Therapeutics with Overweight Rating, Announces Price Target of $47

Barclays analyst Etzer Darout initiates coverage on Janux Therapeutics with a Overweight rating and announces Price Target of $47.

View more
Barclays Initiates Coverage On Janux Therapeutics with Overweight Rating, Announces Price Target of $47
Analyst Upgrades

Truist Securities Initiates Coverage On Janux Therapeutics with Buy Rating, Announces Price Target of $100

Truist Securities analyst Asthika Goonewardene initiates coverage on Janux Therapeutics with a Buy rating and announces Price Target of $100.

View more
Truist Securities Initiates Coverage On Janux Therapeutics with Buy Rating, Announces Price Target of $100
Analyst Upgrades

Stifel Reinstates Buy on Janux Therapeutics, Announces $45 Price Target

Stifel analyst Bradley Canino reinstates Janux Therapeutics with a Buy and announces $45 price target.

View more
Stifel Reinstates Buy on Janux Therapeutics, Announces $45 Price Target